Skip to content

Clinical trials

Metabolic Diseases trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolic Diseases Country / region: Italy Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20092
20121
20145
20151
20163
20171
20191
20203
20213
20224
20235
20243
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Recruiting6
Terminated5
Active, not recruiting2
Unknown status2
Not yet recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Messina4
89bio, Inc.3
Calcilytix Therapeutics, Inc., a BridgeBio company2
Eli Lilly and Company2
Lo.Li.Pharma s.r.l2
Otsuka Pharmaceutical Development & Commercialization, Inc.2
Alexion Pharmaceuticals, Inc.1
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis1
Azienda Sanitaria-Universitaria Integrata di Udine1
Fondazione Don Carlo Gnocchi ETS1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolic Diseases37
Diabetes Mellitus, Type 27
Diabetes Mellitus6
Endocrine System Diseases5
Glucose Metabolism Disorders5
Non-alcoholic Fatty Liver Disease5
Obesity5
Cardiovascular Diseases4
Genetic Diseases, Inborn4
Dyslipidemias3

Trials

Showing 76 to 37 of 37. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.